NCT00177242View on ClinicalTrials.gov

Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

December 31, 2006

Conditions

Cancer

Interventions

DRUG

Gefitinib

Trial Locations (1)

15232

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

University of Pittsburgh

OTHER